Pacific Biosciences of California Inc.
Organization details
- Legal name
- Pacific Biosciences of California Inc.
- Former names
- Nanofluidics Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Information Technology
- SIC code
- 3826 — Laboratory Analytical Instruments
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Menlo Park
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- PACB
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001299130
- EIN
- 16-1590339
- Wikidata ID
- Q2069106
Board of directors
-
Christopher Gibson · DirectorSince 2026
-
Christopher M. Smith · DirectorSince 2025
-
David Botstein · DirectorSince 2023
-
David W. Meline · DirectorSince 2023
-
Hannah Valantine · DirectorSince 2023
-
John F. Milligan · DirectorSince 2023
-
Kathy Ordonez · DirectorSince 2023
-
Lucy Shapiro · DirectorSince 2023
-
Marshall Mohr · DirectorSince 2023
-
Randall S. Livingston · DirectorSince 2023
-
William W. Ericson · DirectorSince 2023
Director election results
Annual meeting of June 3, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
94.0%
-
95.8%
-
95.9%
-
97.0%
-
97.0%
Board connections
6 of this board's directors also sit on 9 other boards. 2 are in the same sector.
- via John F. Milligan
- via Hannah Valantine
- via Hannah Valantine
- via David W. Meline
-
HP Inc. Same sectorvia David W. Meline
- via John F. Milligan
- via Christopher M. Smith
- via Christopher Gibson
-
Veeva Systems Inc. Same sectorvia Marshall Mohr
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $3,370,095
- 12 sales by 4 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 6, 2026 | Gibson James R II Officer (See Remarks) | Option exercise | +500,000 | $1.18 | $590,000 |
| Oct 6, 2026 | Gibson James R II Officer (See Remarks) | Open-market sale | −661,815 | $3.11 | $2,056,921 |
| Aug 17, 2026 | Van Oene Mark Officer (See Remarks) | Open-market sale | −26,911 | $1.13 | $30,409 |
| Aug 10, 2026 | Van Oene Mark Officer (See Remarks) | Grant or award | +489,130 | — | — |
| Apr 8, 2026 | Christopher Gibson Director | Grant or award | +57,473 | — | — |
| Apr 1, 2026 | Gibson James R II Officer (See Remarks) | Open-market sale | −88,185 | $1.37 | $120,813 |
| Mar 3, 2026 | Christopher Gibson Director | Grant or award | +53,913 | — | — |
| Mar 3, 2026 | Christian O. Henry Officer (See Remarks) | Open-market sale | −12,497 | $1.51 | $18,870 |
| Mar 3, 2026 | Van Oene Mark Officer (See Remarks) | Open-market sale | −6,504 | $1.51 | $9,821 |
| Mar 3, 2026 | Farmer Michele Officer (See Remarks) | Open-market sale | −2,979 | $1.51 | $4,498 |
| Feb 27, 2026 | Farmer Michele Officer (See Remarks) | Grant or award | +89,835 | — | — |
| Feb 27, 2026 | Gibson James R II Officer (See Remarks) | Grant or award | +333,848 | — | — |
| Feb 27, 2026 | Van Oene Mark Officer (See Remarks) | Grant or award | +500,000 | — | — |
| Feb 27, 2026 | Christian O. Henry Officer (See Remarks) | Grant or award | +920,810 | — | — |
| Feb 18, 2026 | Van Oene Mark Officer (See Remarks) | Open-market sale | −55,107 | $1.63 | $89,824 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Pacific Biosciences of California Inc.
How many directors are on Pacific Biosciences of California Inc.'s board?
Pacific Biosciences of California Inc.'s board has 11 directors: Christopher Gibson, Christopher M. Smith, David Botstein, David W. Meline, Hannah Valantine, John F. Milligan, Kathy Ordonez, Lucy Shapiro, Marshall Mohr, Randall S. Livingston and 1 other.
Are Pacific Biosciences of California Inc. insiders buying or selling shares?
Over the last 12 months, Pacific Biosciences of California Inc. insiders made no open-market purchases and sold $3.4 million of shares in 12 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="pacific-biosciences-of-california-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.